Kalaris Therapeutics, Inc. (KLRS) insider trading

Over the last 12 months, 1 insider bought $6.18M and 1 insider sold $12.9K of Kalaris Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.

Latest insider buys and sells

Which funds own Kalaris Therapeutics, Inc.